Co-Authors
This is a "connection" page, showing publications co-authored by Sophia Hober and Elisa Pin.
Connection Strength
0.772
-
Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assay. Clin Transl Immunology. 2021; 10(7):e1312.
Score: 0.239
-
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19. J Intern Med. 2022 01; 291(1):72-80.
Score: 0.061
-
Differences in risk for SARS-CoV-2 infection among healthcare workers. Prev Med Rep. 2021 Dec; 24:101518.
Score: 0.060
-
Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2. EBioMedicine. 2021 Aug; 70:103523.
Score: 0.060
-
Persisting Salivary IgG Against SARS-CoV-2 at 9 Months After Mild COVID-19: A Complementary Approach to Population Surveys. J Infect Dis. 2021 08 02; 224(3):407-414.
Score: 0.060
-
High Amounts of SARS-CoV-2 Precede Sickness Among Asymptomatic Health Care Workers. J Infect Dis. 2021 07 02; 224(1):14-20.
Score: 0.060
-
False Positive Results in SARS-CoV-2 Serological Tests for Samples From Patients With Chronic Inflammatory Diseases. Front Immunol. 2021; 12:666114.
Score: 0.059
-
SARS-CoV-2 infections amongst personnel providing home care services for older persons in Stockholm, Sweden. J Intern Med. 2021 Aug; 290(2):430-436.
Score: 0.059
-
Antibodies to SARS-CoV-2 and risk of past or future sick leave. Sci Rep. 2021 03 04; 11(1):5160.
Score: 0.058
-
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden. Nat Commun. 2020 10 08; 11(1):5064.
Score: 0.057